{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:21:12Z","timestamp":1790104872776,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jinf.2018.01.011","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:52:50Z","timestamp":1518180770000},"page":"483-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Usefulness of \u00df-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients"],"prefix":"10.1016","volume":"76","author":[{"given":"J.","family":"Guitard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-D.","family":"Tabone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Antignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8037-8967","authenticated-orcid":false,"given":"Y.","family":"Senghor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.01.011_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.01.011_bib0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2015.181","article-title":"Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis","volume":"50","author":"Montesinos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2018.01.011_bib0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.01.011_bib0025","doi-asserted-by":"crossref","first-page":"O50","DOI":"10.1111\/1469-0691.12312","article-title":"A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies","volume":"20","author":"Gamaletsou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2018.01.011_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2009.08072.x","article-title":"Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant","volume":"149","author":"Hale","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jinf.2018.01.011_bib0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal infections in pediatric oncology","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jinf.2018.01.011_bib0040","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1111\/j.1469-0691.2012.03819.x","article-title":"Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000\u20132007","volume":"18","author":"De Castro","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2018.01.011_bib0045","first-page":"3839","article-title":"Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry","volume":"24","author":"Della Pepa","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jinf.2018.01.011_bib0050","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.jinf.2018.01.011_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.leukres.2004.10.003","article-title":"Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment","volume":"29","author":"Masood","year":"2005","journal-title":"Leuk Res"},{"issue":"Suppl 7","key":"10.1016\/j.jinf.2018.01.011_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2018.01.011_bib0065","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.01.011_bib0070","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2018.01.011_bib0075","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jinf.2018.01.011_bib0080","doi-asserted-by":"crossref","first-page":"ofw128","DOI":"10.1093\/ofid\/ofw128","article-title":"Prospective evaluation of serum beta-glucan testing in patients with probable or proven fungal diseases","volume":"3","author":"Angebault","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"16","key":"10.1016\/j.jinf.2018.01.011_bib0085","doi-asserted-by":"crossref","first-page":"21484","DOI":"10.18632\/oncotarget.7471","article-title":"(1, 3)-beta-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies","volume":"7","author":"Azoulay","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jinf.2018.01.011_bib0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2016.07.007","article-title":"Detection of beta-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy","volume":"73","author":"Guitard","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.01.011_bib0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10096-014-2302-9","article-title":"How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors","volume":"34","author":"Hammarstrom","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2018.01.011_bib0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/CVI.00025-07","article-title":"Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting","volume":"14","author":"Smith","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2018.01.011_bib0105","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.01.011_bib0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jinf.2018.01.011_bib0115","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/JCM.00673-15","article-title":"Evaluation of a novel plasma (1,3)-beta-d-glucan detection assay for diagnosis of candidemia in pediatric patients","volume":"53","author":"Liu","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2018.01.011_bib0120","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses"},{"key":"10.1016\/j.jinf.2018.01.011_bib0125","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/mmy\/myu066","article-title":"Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia","volume":"52","author":"Abe","year":"2014","journal-title":"Med Mycol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:31Z","timestamp":1759008331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318300562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0163445318300562"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.01.011","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of \u00df-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}